Literature DB >> 14639601

Suppression of 6A8 alpha-mannosidase gene expression reduced the potentiality of growth and metastasis of human nasopharyngeal carcinoma.

Wei Yue1, Yu Lan Jin, Geng Xian Shi, Yin Liu, Yang Gao, Fang Tao Zhao, Ling Ping Zhu.   

Abstract

Suppression of alpha-mannosidases by chemicals has been shown to reduce the potentiality of growth and metastasis of various tumors. In our study, the effect of 6A8 alpha-mannosidase (MAN 6A8), recently discovered in our laboratory, on malignant behaviors of tumor cells was examined. Since the suppressive effect of chemicals on alpha-mannosidase is not specific, antisense technique was used to specifically inhibit expression of the MAN 6A8 in human nasopharyngeal carcinoma cells, CNE-2L2. Two cell clones, AS1 and AS2, with pronounced suppression of MAN 6A8 expression were developed. Wild-type (W), mock-transduced (M) and irrelevant DNA-transduced (IR) CNE-2L2 cells with normal expression of the enzyme were used as controls. Malignant behaviors of the cells were examined. Significant inhibition of growth of AS cells in vitro measured by MTT assay, colony formation and anchorage-independent colony formation was found. Pronounced inhibition of formation of tumors from AS cells inoculated into nude mice and metastasis was also observed. W, M and IR cells cultured in plate wells appeared dispersed with a fibroblastic or epithelial morphology, whereas AS cells were in compact sheets with an epithelioid organization. Since E-cadherin is the key factor in homophilic adhesion of epithelial cells, its expression on the surface of CNE-2L2 cells was determined. E-cadherin expression on AS cells was enhanced, whereas it was markedly diminished on W, M and IR cells. In addition, lamellipodia, which play an important role in cell spreading and mobility, almost disappeared on AS cells. The results demonstrate a significant suppressive effect of reduced expression of MAN 6A8 on malignant behaviors of CNE-2L2 cells. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14639601     DOI: 10.1002/ijc.11536

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

2.  α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells.

Authors:  Lizhi He; Catherine Fan; Anil Kapoor; Alistair J Ingram; Adrian P Rybak; Richard C Austin; Jeffery Dickhout; Jean-Claude Cutz; James Scholey; Damu Tang
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

Review 3.  Generation and degradation of free asparagine-linked glycans.

Authors:  Yoichiro Harada; Hiroto Hirayama; Tadashi Suzuki
Journal:  Cell Mol Life Sci       Date:  2015-03-14       Impact factor: 9.261

4.  Man2C1, an alpha-mannosidase, is involved in the trimming of free oligosaccharides in the cytosol.

Authors:  Tadashi Suzuki; Izumi Hara; Miyako Nakano; Masaki Shigeta; Takatoshi Nakagawa; Akihiro Kondo; Yoko Funakoshi; Naoyuki Taniguchi
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

5.  Accumulation of free oligosaccharides and tissue damage in cytosolic α-mannosidase (Man2c1)-deficient mice.

Authors:  Silvia Paciotti; Emanuele Persichetti; Katharina Klein; Anna Tasegian; Sandrine Duvet; Dieter Hartmann; Volkmar Gieselmann; Tommaso Beccari
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

6.  Dual functions for cytosolic α-mannosidase (Man2C1): its down-regulation causes mitochondria-dependent apoptosis independently of its α-mannosidase activity.

Authors:  Li Wang; Tadashi Suzuki
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

7.  hMan2c1 transgene promotes tumor progress in mice.

Authors:  Z G Xiang; D D Jiang; Y Liu; L F Zhang; L P Zhu
Journal:  Transgenic Res       Date:  2009-07-02       Impact factor: 2.788

8.  Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism.

Authors:  Austin T Ryan; Anunay J Pulukuri; Maryam Davaritouchaee; Armina Abbasi; Aaron T Hendricksen; Larissa K Opp; Anthony J Burt; Amy E Nielsen; Rock J Mancini
Journal:  Acta Pharmacol Sin       Date:  2020-05-25       Impact factor: 6.150

Review 9.  The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.

Authors:  Daniel J Turnham; Nicholas Bullock; Manisha S Dass; John N Staffurth; Helen B Pearson
Journal:  Cells       Date:  2020-10-22       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.